Life sciences companies must go beyond digitizing individual operations, and instead harness digital to design and construct entirely new business models, writes Brags Srinivasan.
Brags Srinivasan
Advertisement
Brags Srinivasan is Managing Director, Life Sciences – Technology, Accenture.
Articles by Brags Srinivasan
Advertisement
Latest Updated Articles
- Harnessing Digital to Construct New Business Models
Published: October 1st 2015 | Updated:
Advertisement
Advertisement
Trending on PharmExec
1
Relation Therapeutics Forms $1.7 Billion Multi-Program Collaboration with Novartis Advancing Therapeutics for Atopic Diseases
2
Eli Lilly’s Jaypirca Achieves Primary Endpoint in Head-to-Head Phase III Study Against Imbruvica Treating CLL/SLL
3
Pfizer Enters Exclusive Collaboration and License Agreement with Yao Pharma for Oral Small-Molecule GLP-1 Agonists
4
Is FDA Streamlining Regulations in the Biosimilar Space?
5
